Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
67,598,721
-
Share change
-
+5,840,113
-
Total reported value
-
$261,589,769
-
Put/Call ratio
-
143%
-
Price per share
-
$3.87
-
Number of holders
-
122
-
Value change
-
+$26,227,730
-
Number of buys
-
52
-
Number of sells
-
63
Institutional Holders of IMMUNOGEN INC - COMMON STOCK (IMGN) as of Q1 2017
As of 31 Mar 2017,
IMMUNOGEN INC - COMMON STOCK (IMGN) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,598,721 shares.
The largest 10 holders included
Clearbridge Investments, LLC, ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, Redmile Group, LLC, PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, DEUTSCHE BANK AG\, WELLS FARGO & COMPANY/MN, and STATE STREET CORP.
This page lists
122
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.